0.38
+0.0077(+2.09%)
Currency In USD
| Previous Close | 0.37 |
| Open | 0.36 |
| Day High | 0.39 |
| Day Low | 0.36 |
| 52-Week High | 1.8 |
| 52-Week Low | 0.31 |
| Volume | 547,505 |
| Average Volume | 713,966 |
| Market Cap | 12.25M |
| PE | -0.44 |
| EPS | -0.86 |
| Moving Average 50 Days | 0.77 |
| Moving Average 200 Days | 1.08 |
| Change | 0.01 |
If you invested $1000 in Femasys Inc. (FEMY) since IPO date, it would be worth $31.33 as of September 08, 2025 at a share price of $0.376. Whereas If you bought $1000 worth of Femasys Inc. (FEMY) shares 3 years ago, it would be worth $222.43 as of September 08, 2025 at a share price of $0.376.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios
GlobeNewswire Inc.
Sep 02, 2025 1:00 PM GMT
--Existing investors, including Femasys’ largest shareholders, reaffirm confidence in Femasys’ strategy for growth and impact in women’s health-- ATLANTA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovato
Femasys Announces Pricing of $8.0 Million Underwritten Public Offering
GlobeNewswire Inc.
Aug 26, 2025 3:44 AM GMT
ATLANTA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (the “Company” or “Femasys”), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible, in
Femasys Announces FemSperm™ Kit to Activate Gynecologists and Advance FemaSeed® Fertility Platform
GlobeNewswire Inc.
Aug 21, 2025 1:00 PM GMT
-- First in the FemSperm family, the Setup Kit enables gynecologists to offer FemaSeed directly, expanding access ahead of IVF and driving revenue growth -- ATLANTA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedica